DRUG STUDY DRUG NAME BRAND: Docard GENERIC: Dopamine HCL DOSAGE: 2 amp in D5W 250cc @ 10 mgtts/min

titrate by increment of 3 mgtts/ min CLASSIFICATION Sympathomimetic MECHANISM OF ACTION Exogenously administered, it produces direct stimulation of beta-1 receptors and variable stimulations. INDICATION/ CONTRAINDICATION Indications: Correction of hemodynamic imbalances present in renal failure. Contraindications: Uncorrected tachyarrythmias or ventricular fibrillation. NURSING CONSIDERATIONS Nausea, vomiting, 1.]Monitor vital tachycardia, signs and ECG anginal pain, during infusion. If palpitation, BP drops dysnea, headache, 30mmHg stop hypotension, infusion and report hypertension, to physician. vasoconstriction, decrease urine 2.]Assess for output, dyspnea. oxygenation and perfusion deficit: dyspnea, cyanosis, decrease BP, chest pain, dizziness. 3.]Assess patient¶s GI complaints: nausea and vomiting. 4.]Monitor BP closely for sudden drop after drug is stopped. SIDE EFFECTS

DRUG NAME

CLASSIFICATION

MECHANISM OF ACTION

INDICATION/ CONTRAINDICATIO N

SIDE EFFECTS

NURSING CONSIDERATIONS

BRAND:

Alkalinizing agent, Antacid, Electrolyte

GENERIC: Sodium bicarbonate

Increases plasma Indications: bicarbonate, which excess buffers H ion Treatment of metabolic acidosis. concentration; reverses metabolic acidosis. Contraindications: Edema, hypertension, severe kidney insufficiency, hypoventilation.

Metabolic alkalosis (dizziness, cramps, thirst, anorexia, N & V, tetany, seizures). Paravenous administration may lead to tissue necrosis.

1.]Assess respiratory and pulse rate. 2.]Monitor fluid balance. 3.]Assess for the symptoms of alkalosis. 4.]Teach patient about sodium restricted diet.

DOSAGE: 650mg 1tab TID

DRUG NAME

CLASSIFICATION

MECHANISM OF ACTION

INDICATION/ CONTRAINDICATIO N Indications: Moderate to severe diabetic ketoacidosis or hyperosmolar hyperglycemia regular insulin. Mild diabetic ketoacidosis. Newly diagnosed diabetes.

SIDE EFFECTS

NURSING CONSIDERATIONS

BRAND: Humulin R

Insulin product, antidiabetic agent

GENERIC: Insulin injection (Regular insulin)

Increases glucose transport across muscle and fat cell membranes to reduce glucose level.

Hypoglycemia, insulin resistance, local and generalized allergic reaction.

1. ]Assess V/S. 2. ]Use a tuberculin or insulin syringe for accuracy of measurement. 3. ]Keep in cold location, preferably a refrigerator. 4. Do not freeze. 5. ]Observe closely for S&S of hyper- or hypoglycemia until dosage established. 6.] Monitor BP, BS, LDL, cholesterol and HbA1c.

Contraindications: Hypoglycemia. Hypersensitivity to insulin.

DOSAGE: 6 ³u´ IV now

DRUG NAME

CLASSIFICATION

MECHANISM OF ACTION

INDICATION/ CONTRAINDICATIO N Indications: Diabetes mellitus. In combination with sulfonylureas to treat high blood glucose n adults over 65 years of age.

SIDE EFFECTS

NURSING CONSIDERATIONS

BRAND: Humalog mix 25

Rapid-acting insulin, Anti diabetic agent

GENERIC: Insulin lispro injection

Facilitates the transport of glucose into cardiac and skeletal muscle and adipose tissue. It also increases synthesis of glycogen in the liver.

Hypersensitivity to insulin.

1. ]Document disease onset, level of control previous agents trialed, and the outcome. 2.] Monitor VS, CBC, HbA1c, U/A; microalbumin and renal function studies. 3. ]Review signs and symptoms of hypoglycemia and appropriate management. 4. ]Continue BP control, diet and exercise for disease control.

Contraindications: DOSAGE: 25 µu¶ SQ 10 mins BB, 12 µu´ SQ 10 mins BS Use during episodes of hypoglycemia. Hypersensitivity to insulin lispro.

DRUG NAME BRAND: Encifer

CLASSIFICATION Vitamins & Minerals

MECHANISM OF ACTION Hematinic. Iron sucrose is dissociated by the reticuloendothel ial system into iron and sucrose. Encifer iron component appears to distribute mainly in the blood and to some extent in the extravascular fluid.

INDICATION/ CONTRAINDICATIO N Indications: Treatment of iron deficiency anemia in the following patients: Hemodialysis Dependent Chronic Kidney Disease (HDD-CKD) patients receiving an erythropoietin. Contraindications: Patients with evidence of iron overload, in patients with known hypersensitivity to iron sucrose or any of its inactive components and in patients with anemia not caused by iron deficiency.

SIDE EFFECTS Hypotension, chest pain, hypertension, hypervolemia, CHF, cramps, musculoskeletal pain, diarrhea, nausea, vomiting, abdominal pain, elevated liver enzymes, skin irritation, pruritis, application site reaction, dizziness, dyspnea, pneumonia, cough, headache, fever, asthenia, malaise. .

NURSING CONSIDERATIONS 1. ]Watch for serious hypersensitivity reactions of iron sucrose. 2. ]Medication is administered 1 to 3 times/wk. Do not administer more than 3 times/wk. 3. ]For IV administration only.

GENERIC : Iron sucrose

DOSAGE: Amp 20 mg/mL (brown, sterile, aqueous soln) x 5's.

Sign up to vote on this title
UsefulNot useful